116. Fareed J. Venous thromboprophylaxis in the 1990: a perspective // Sem. Thromb. Haemost. - 1991. - Vol. 17. - № 4. - P. 317 - 321.
117. Flier J. S., Heistad D. D. Platelet-endotelium interactions // N. Engl. J. Med. – 1993. – V. 328. – P.628 - 635.
118. Florell S. R., Rodgers G. M. Inherited thrombotic disorders: an update // Am. J. Hematol. – 1997. - Jan, 54:1, 53 – 60.
119. Foley P. W., Irvine C. D., Standen G. R., Morse C., Smith F. T., Mc Grath C., Baird R. N., Lamont P. M. Activated protein C resistance, factor V Leiden and peripheral vascular disease // rg. – 1997. - Apr, 5:2, 157 – 60.
120. Gable D. R., Bergamini T. M., Livingston C. K., Richardson J. rgical implications of hypercoagulable syndromes // rg. – 1997. - Feb, 63:2, 163 – 9.
121. Gallus A. S. Anticoagulants in the prevention of venous thromboembolism // Baillieres. Clin. Haematol. - 1990. - Vol 3. - № 3. – P. 651 - 684.
122. Gallus A. S., Hirsh J., Tuttle R. et al. Small subcutaneous doses of heparin in prevention of venous thrombosis // New. Engl. J. Med. - 1973. - Vol. 288. - P. 545 - 554.
123. Gandrille S., Borgel D., Sala N., Espinosa-Parrilla Y., Simmonds R., Rezende S., et al. Protein S deficiency: a database of mutations - summary of the first update // Thromb Haemost – 2000. 84:918.
124. Ginsberg J. S., Wells P. S., Brill-Edwards P. et al. Antiphospholipid antibodies and venous thrombosis // Blood. - 1995. - Vol. 86. - P. 3685 - 3691.
125. Giri T. K., Linse S., de Frutos P. G., Yamazaki T., Villoutreix B. O., Dahlback B. Structural requirements of anticoagulant protein S for its binding to the complement regulator C4b-binding protein // J Biol Chem – 2002. 277:15099-106.
126. Giri T. K., Yamazaki T., Sala N., Dahlback B., de Frutos P. G. Deficient APC-cofactor activity of protein S Heerlen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors // Blood – 2000. - 96: 523-31.
127. Girolami A., Simioni P., Scarano L., Girolami B. Venous and arterial thrombophilia // Haematologica. – 1997. - Jan, 82:1, 96 – 100.
128. Haas S. The role of low-molecular-weight heparins in the prevention of venous thrombosis in surgery with special reference to enoxaparin // Haemostasis. - 1996. - Vol. 26. - № 2. - P. 39 - 48.
129. Haichman R. L., Pollii M. Advances in Inflammation Research // New York. – 1979. - V. 1. - P. 169 - 173.
130. Hansberry K. L., Thompson I. M.Jr., Bauman J. et al. A prospective comparison of thromboembolic stockings, external sequential pneumatic compression stockings and heparin sodium /dihydroergotamine mesylate for the prevention of thromboembolic complications in urological surgery // J. Urol. -1991. - Vol. 145. - № 6. - P. 1205 - 1208.
131. Harker L. A., Hanson S. R., Kelly A. B. Antithrombotic strategies targening thrombin activities, thrombin receptors and thrombin generation // Thromb. Haemost. – 1997. - Jul, 78:1, 736 – 41.
132. Harris E. N., Charavi A. E., Boey M. L. et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus // Ibid. - 1983. - Vol.2. - P. 1211 - 1214.
133. Heeb M. J., Griffin J. H. Activated protein C-dependent and - independent anticoagulant activities of protein S have different structural requirements // Blood Cells, Molecules and Diseases – 2002. 29:190-9.
134. High K. A. Antithrombin III, protein C and protein S. Naturally occurring anticoagulant proteins // Arch. Pathol. Lab. Med. - 1988. - Vol. 112. - P. 28 - 40.
135. Hirsh J., Hoak J. Managament of deep vein thrombosis and pulmonary embolism // A statement for healthcare professionals from the council on thrombosis. American Heart Association. - 1996.
136. Hughes G. R. V., Gharavi A. E., Harris A. E. The anticardiolipin syndrome // J. Rheum. - 1986. - Vol. 13. - P. 486 - 489.
137. Hunt В. J., Khamashta M. A. Management of the Hughes syndrome // Clin. exp. Rheum. - 1996. - Vol. 14. - P. 115 - 117.
138. Iida H., Nakahara M., Komori K., Fujise M., Wakiyama M., Urata M., et al. Failure in the detection of aberrant mRNA from the heterozygotic splice site mutant allele for protein S in a patient with protein S deficiency // Thromb Res – 2001. - 102: 187-96.
139. Ikeda K., Nagasawa K., Horiuchi T., Tsuru T., Nishizaka H., Niho Y. C5a induces tissue factor activity on endothelial cells // Thromb. Haemost. - 1997. – Feb, 77(2):394 – 8.
140. Inada K., Koike S., Shizai N. et al. Effects of intermittent pneumatic leg compression for prevention of postoperative deep venous thrombosis with special reference to fibrinolytic activity // Amer. rg. - 1988. - Vol.15. - №4. - P. 537 - 630.
141. Insko E. K., Haskal Z. J. Antiphospholipid syndrome: patterns of life-threatening and severe recurrent vascular complications // Radiology. – 1997. - Feb, 202:2, 319 – 26.
142. Jeffery Р. С., Nicolaides A. N. Graduated compression stockings in the prevention of postoperative deep vein thrombosis // Brit. rg. - 1990. - Vol. 77. - P. 380 - 383.
143. Kakkar V. V. Prevention and management of venous thrombosis // Brit. med. Bull. – 1994. - № 50. - P. 871 - 903.
144. Kakkar V. V. Prevention of fatal pulmonary embolism // Haemostasis. - 1993. - Vol. 23 (suppl. 1). - P. 42 - 50.
145. Kakkar V. V., Field E. S., Nicolaides A. N. et al. Low doses of heparin in prevention of deep vein thrombosis // Lancet. - 1971. - Vol. 2. - № 000. - P. 669 - 671.
146. Kapiotis S., Speiser W., Pabinger-Fasching I., Kyrle P. A., Lechner K. Anticardiolipin antibodies in patients with venous thrombosis // Haemostasis. – 1991., 21:1, 19 – 24.
147. Kearon С., Hirsh J. Starting prophylaxis for venous thromboembolism postoperatively // Arch. intern. Med. - 1995. - Vol. 155. - P. 366 - 372.
148. Levy P. J., Gonzalez F. M., Rush D. S., Haynes J. L. Hypercoagulable states as an evolving risk for spontaneous venous and arterial thrombosis // J. Am. rg. – 1994. - Mar, 178:3, 266 – 70.
149. Liberti G., Bertina R. M., Rosendaal F. R. Hormonal state rather than age influences cut-off values of protein S: reevaluation of the thrombotic risk associated with protein S deficiency // Thromb Haemost – 1999. 82:1093-6.
150. Lopaciuk S., Bykowska K., Kopec M. Prevalence of heparin cofactor II deficiency in patients with a history of venous thrombosis // Pol. J. Pharmacol. – 1996. - Jan, 48:1, 109 – 11.
151. Lowe G. D., Greer L. A., Cooke T. G. et al. Risk of and prophylaxis for venous thromboembolism in hospital patients // Brit. Med. J. – 1992. - Vol. 305. - P. 567 - 574.
152. Makris M., Leach M., Beauchamp N. J., Daly M. E., Cooper P. C., Hampton K. K., et al. Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S // Blood – 2000. - 95:1935-41.
153. Martin М. Fibrinolysis and heparin therapy of deep vein thrombosis intern // J. Angiol. - 1996. - N 5. - P. 13 - 21.
154. Meroni P. L., Tincani A., Barcellini W., Del Papa N., Gambini D., Piona A., La Rosa L., Balestrieri G. What is the pathogenetic role of antiphospholipid antibodies? // Clin. Exp. Rheumatol. – 1994. - Sep, 12 Suppl. 10, S 43 – 7.
155. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology and pharmacology // Pharmacol. Rev. – 1991. – Vol. 43. - P. 108 - 142.
156. Moser K. M. Venous thromboembolism // Amer. Rev. resp. Dis. - 1990. - Vol. 141. - P. 235 - 249.
157. Muller-Eberhard H. J., In: Brent L., Holborrow J. Progres in Immunology // Amsterdam. – 1974. - V. 1. - P. 173.
158. Nair C. H., Shah G. A., Dhall D. P. Operation, dextran and fibrin network structure // Clin. Invest. Med. – 1985. - № 8 - P. 125 - 128.
159. Nakahara M., Iida H., Urata M., Fujise M., Wakiyama M., Kinoshita S., et al. A novel splice acceptor site mutation of protein S gene in affected individuals with type I protein S deficiency: allelic exclusion of the mutant gene // Thromb Res – 2001. - 101:387-93.
160. Naschitz J. E., Yeshurun D., Eldar S., Lev L. M. Diagnosis of cancer-associated vascular disorders // Cancer. – 1996. - May, 77:9, 1759 – 67.
161. Neve P. Non-neoplastic hypercoagulability states // Rev. Med. Brux. – 1991. - Dec, 12:10, 402 – 6.
162. Nowak-Gettl U., Kreuz W. D., Krackhardt B., Freund H., Funk M., Linde R., Jacobi G., Scharrer I. Physiologic blood coagulation studies in idiopathic arterial thrombosis // Monatsschr. Kinderheilkd. – 1992. - Mar, 140:3, 183 – 7.
163. Olivecrona Т., Bengtsson-Olivecrona G. Lipoprotein lipase:an attempt to correlate its molecular properties to its function // Int. J. Obes. - 1985. - Vol.9. - P. 109 - 116.
164. Packham M. A. Role of platelets in thrombosis and hemostasis // Can. J. Physiol. Pharmacol. – 1994. - Mar, 72:3, 278 – 84.
165. Pearson J. D. Endothelial cell function and thrombosis // Baillieres. Clin. Haematol. – 1994. - Sep, 7:3, 441 – 52.
166. Perler B. A. Hypercoagulability and the hypercoagulability syndromes // Am. J. Roentgenol. – 1995. - Mar, 164:3, 559 – 64.
167. Pollock A. V. Calf-muscle stimulation as a prophylactic method against deep vein thrombosis // Triangle. - 1977. - Vol. 16. - № 1. - P. 41 - 45.
168. Prentice C. R. Pathogenesis of thrombosis // Haemostasis. – 1990., 20, Suppl 1:, 50 – 9.
169. Reiter W., Ehrensberger М., Sheinbrucrer B. et al. Parameters of haemostasis during acute venous thrombosis // Thromb. Haemost. - 1995. - Vol. 74. - № 2. - P. 596 - 601.
170. Rezende S. M., Lane D. A., Zoller B., Mille-Baker B., Laffan M., Dalhback B., et al. Genetic and phenotypic variability between families with hereditary protein S deficiency // Thromb Haemost – 2002. - 87:258-65.
171. Ridker P. M., Hennekens C. H., Lindpaintner K., Stampfer M. J., Eisenberg P. R.; Miletich J. P. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men // N. Engl. J. Med. – 1995. - Apr, 332:14, 912 – 7.
|
Из за большого объема этот материал размещен на нескольких страницах:
1 2 3 4 5 6 |
